The Centers for Disease Control and Prevention today issued updated recommendations for managing and reporting Shigella infections that were treated with ciprofloxacin or azithromycin and resulted in possible clinical treatment failure. “If treatment failure is suspected, clinicians should consider consulting an infectious disease specialist to identify best treatment options, and submit a stool specimen for antimicrobial susceptibility testing,” CDC said. “Clinicians should monitor patients carefully and report cases of possible clinical treatment failure to CDC.” Shigella bacteria can cause Shigellosis, a diarrheal disease that should be reported to local health departments. 

Related News Articles

Headline
The U.S. Preventive Services Task Force today recommended a pill that helps prevent the spread of HIV to high-risk patients.
Headline
The Centers for Disease Control and Prevention yesterday reported 1,001 cases of measles so far this year, according to the Department of Health and Human…
Headline
Overall cancer death rates continue to decline for U.S. men, women and children, according to the latest Annual Report to the Nation on the Status of Cancer.
Headline
After increasing for almost two decades, the annual number of new diabetes cases in U.S. adults fell by 35 percent between 2008 and 2017, to 1.3 million.
Headline
The White House yesterday released a strategy to guide the federal government in protecting the nation from infectious disease threats by working with other…
Headline
The Centers for Disease Control and Prevention has released a toolkit to help health care providers talk with parents about measles and the measles vaccine,…